(ft. 康博醫創 吳夢楚 董事長 & 洪灝 營運長)臨床上病人如果受感染要檢測病原,以血液培養而言,可能長達七天。後來科學家從分子足跡去找病原,因而有 PCR 檢測,甚至是這幾年的 NGS 方法,逐漸在技術上突破。即使如此,檢測時間還是需要數天,能再快一點嗎? 單集內容👉https://podcast.biomeder.com/episodes/micronbrane-medical-pathogen-test (00:00:20) 臨床病原檢測的議題 (00:01:56) 康博醫創吳董事長&洪營運長 (00:03:41) 臨床病原檢測,目前怎麼做? (00:08:30) 從分子足跡看病原:PCR、次世代定序(NGS)的特點 (00:14:24) 即使有了NGS,還有什麼限制? (00:20:23) 技術上的突破,濾掉不要的標的-人源的核酸 (00:33:40) 實驗室試劑&耗材+分析軟體,B2B的商業模式 (00:37:35) 生醫新創策略和心得 (00:44:08) IVD產品開發時程 (00:47:53) 新創能如何開發收入來源 (00:51:07) 精準醫療上的應用 #本集節目中提到的創新病原檢測技術,目前在RUO(Research Use Only)階段,和專業實驗室、研究單位合作來使用,非醫療器材,也非消費者能自行操作的臨床檢測。 留言告訴我你對這一集的想法: https://open.firstory.me/story/ckvrns7egcrrr0989l0yfxiug?m=comment ✎ 留言: podcast.biomeder.com/contact-us 🖄 Email: [email protected] 💰 小額支持: biomeder.com/product/pay-to-recognition 《生醫人生旅歷》podcast.biomeder.com 《BioMeder生醫人網摘》biomeder.com 這個節目,由生醫人文化科技製作播出。 Powered by Firstory Hosting
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare